{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:06:25Z","timestamp":1790017585280,"version":"4.0.1"},"reference-count":234,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Endothelial dysfunction (ED) is frequently encountered in transplant medicine. ED is an argument of high complexity, and its understanding requires a wide spectrum of knowledge based on many fields of basic sciences such as molecular biology, immunology, and pathology. After hematopoietic stem cell transplantation (HSCT), ED participates in the pathogenesis of various complications such as sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD), graft-versus-host disease (GVHD), transplant-associated thrombotic microangiopathy (TA-TMA), idiopathic pneumonia syndrome (IPS), capillary leak syndrome (CLS), and engraftment syndrome (ES). In the first part of the present manuscript, we briefly review some biological aspects of factors involved in ED: adhesion molecules, cytokines, Toll-like receptors, complement, angiopoietin-1, angiopoietin-2, thrombomodulin, high-mobility group B-1 protein, nitric oxide, glycocalyx, coagulation cascade. In the second part, we review the abnormalities of these factors found in the ED complications associated with HSCT. In the third part, a review of agents used in the treatment of ED after HSCT is presented.<\/jats:p>","DOI":"10.3390\/jcm11030623","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:02:53Z","timestamp":1643194973000},"page":"623","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7840-4414","authenticated-orcid":false,"given":"Giuseppe","family":"Milone","sequence":"first","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bellofiore","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Leotta","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Antonio","family":"Milone","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cupri","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-4755","authenticated-orcid":false,"given":"Andrea","family":"Duminuco","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Garibaldi","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unita\u2019 di Trapianto di Midollo, Azienda Ospedaliera Universitaria Policlinico-San Marco, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Neubauer, K., and Zieger, B. (2021). Endothelial cells and coagulation. Cell Tissue Res.","DOI":"10.1007\/s00441-021-03471-2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/viru.26482","article-title":"Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock","volume":"5","author":"Donadello","year":"2014","journal-title":"Virulence"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: Tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20200652","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_7","first-page":"e138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3389\/fimmu.2018.02886","article-title":"Editorial: Endothelial Dysfunction During Inflammation and Alloimmunity","volume":"9","author":"Penack","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/hr.2012.138","article-title":"Endothelial dysfunction and hypertension in aging","volume":"35","author":"Higashi","year":"2012","journal-title":"Hypertens. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/dc11-s239","article-title":"Endothelial dysfunction in diabetes: The role of reparatory mechanisms","volume":"34","author":"Avogaro","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2021.641427","article-title":"Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?","volume":"12","author":"Lia","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_13","first-page":"575","article-title":"MHC antigen expression in sequential biopsies from cardiac transplant patients--correlation with rejection","volume":"69","author":"Suitters","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/2211-5463.12854","article-title":"Interferon-\u03b3-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase","volume":"10","author":"Maenaka","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nefro.2016.03.023","article-title":"Immune response and histology of humoral rejection in kidney transplantation","volume":"36","author":"Caballero","year":"2016","journal-title":"Nefrologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.healun.2015.10.035","article-title":"ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis","volume":"35","author":"Hammond","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1600-6143.2009.02819.x","article-title":"Effect of Antibodies on Endothelium","volume":"9","author":"Zhang","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-013-1421-x","article-title":"Pathogenesis of graft-versus-host disease: Innate immunity amplifying acute alloimmune responses","volume":"98","author":"Maeda","year":"2013","journal-title":"Int. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","article-title":"Endothelial cell dysfunction: A key determinant for the outcome of allogeneic stem cell transplantation","volume":"56","author":"Luft","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1111\/j.1742-4658.2005.04979.x","article-title":"Induction of PAI-1 expression by tumor necrosis factor \u03b1 in endothelial cells is mediated by its responsive element located in the 4G\/5G site","volume":"272","author":"Swiatkowska","year":"2005","journal-title":"FEBS J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhou, L., Yan, C., Gieling, R.G., Kida, Y., Garner, W., Li, W., and Han, Y.-P. (2009). Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1. BMC Immunol., 10.","DOI":"10.1186\/1471-2172-10-15"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1159\/000445570","article-title":"TNF-\u03b1 Activates High-Mobility Group Box 1-Toll-Like Receptor 4 Signaling Pathway in Human Aortic Endothelial Cells","volume":"38","author":"Yang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340208786241336","article-title":"Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction","volume":"4","author":"Chen","year":"2008","journal-title":"Curr. Hypertens. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/MCB.25.6.2320-2330.2005","article-title":"Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: Role of p47phox phosphorylation and binding to TRAF4","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36142","DOI":"10.1074\/jbc.M405039200","article-title":"Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: Regulation through c-Fos and c-Jun","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00007890-199009000-00033","article-title":"Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans","volume":"50","author":"Symington","year":"1990","journal-title":"Transplantation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.178.2.449","article-title":"PECAM-1 is required for transendothelial migration of leukocytes","volume":"178","author":"Muller","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31830","DOI":"10.1074\/jbc.M804888200","article-title":"Filamin B Mediates ICAM-1-driven Leukocyte Transendothelial Migration","volume":"283","author":"Kanters","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D102-13","DOI":"10.2741\/Cary","article-title":"Focal adhesion kinase in integrin-mediated signaling","volume":"4","author":"Cary","year":"1999","journal-title":"Front. Biosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/bmt.2016.263","article-title":"Sensing danger: Toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Kornblit","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fmed.2020.00352","article-title":"When Innate Immunity Meets Angiogenesis\u2014The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension","volume":"7","author":"Bhagwani","year":"2020","journal-title":"Front. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.RES.0000255032.33661.88","article-title":"Antibody and complement in transplant vasculopathy","volume":"100","author":"Wehner","year":"2007","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.4049\/jimmunol.178.12.7911","article-title":"RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells","volume":"178","author":"Jin","year":"2007","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.humimm.2007.04.003","article-title":"Accommodation of grafts: Implications for health and disease","volume":"68","author":"Tang","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1200\/JCO.2001.19.13.3244","article-title":"Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse","volume":"19","author":"Sievers","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s40263-018-0582-9","article-title":"Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies","volume":"32","author":"Gust","year":"2018","journal-title":"CNS Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18997","DOI":"10.1038\/s41598-020-76055-9","article-title":"Description of neurotoxicity in a series of patients treated with CAR T-cell therapy","volume":"10","author":"Belin","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"577027","DOI":"10.3389\/fimmu.2020.577027","article-title":"Cytokines in CAR T Cell-Associated Neurotoxicity","volume":"11","author":"Gust","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cvr\/cvv144","article-title":"Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis","volume":"107","author":"Flemming","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2011-08-375816","article-title":"Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/labinvest.2010.141","article-title":"High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response","volume":"91","author":"Duan","year":"2011","journal-title":"Lab. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/MCB.23.8.2658-2668.2003","article-title":"A unique autophosphorylation site on Tie2\/Tek mediates Dok-R phosphotyrosine binding domain binding and function","volume":"23","author":"Jones","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","article-title":"Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo","volume":"8","author":"Dumont","year":"1994","journal-title":"Genes Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bjp.0705259","article-title":"Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production","volume":"139","author":"Pizurki","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","article-title":"Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia","volume":"14","author":"Gavard","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/hh1801.097034","article-title":"Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression","volume":"89","author":"Kim","year":"2001","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","article-title":"Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway","volume":"275","author":"Papapetropoulos","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2019-Kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yexcr.2004.04.013","article-title":"Akt is a major angiogenic mediator downstream of the Ang1\/Tie2 signaling pathway","volume":"298","author":"DeBusk","year":"2004","journal-title":"Exp. Cell Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1172\/JCI66549","article-title":"Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis","volume":"123","author":"Ziegler","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Van der Heijden, M., van Nieuw Amerongen, G.P., van Bezu, J., Paul, M.A., Groeneveld, A.B.J., and van Hinsbergh, V.W.M. (2011). Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023448"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jth.13376","article-title":"Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability","volume":"14","author":"Rathnakumar","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10456-020-09730-0","article-title":"Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients","volume":"23","author":"Smadja","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.CCM.0000297955.02633.A4","article-title":"Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury","volume":"36","author":"Huang","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1167\/iovs.07-1206","article-title":"The angiopoietin\/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy","volume":"49","author":"Cai","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_72","first-page":"39","article-title":"Changes in the natural anticoagulants following bone marrow transplantation","volume":"5","author":"Harper","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"ref_73","first-page":"497","article-title":"High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma","volume":"8","author":"Gordon","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"ref_74","first-page":"499","article-title":"von Willebrand factor as a marker of endothelial cell activation following BMT","volume":"10","author":"Collins","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"ref_75","first-page":"253","article-title":"Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies","volume":"12","author":"Catani","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"ref_76","first-page":"747","article-title":"Parameters of the fibrinolytic system in patients undergoing BMT: Elevation of PAI-1 in veno-occlusive disease","volume":"14","author":"Salat","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","article-title":"Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation","volume":"19","author":"Park","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.TP.0000136988.38919.FB","article-title":"Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation","volume":"78","author":"Pihusch","year":"2004","journal-title":"Transplantation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10428199909093722","article-title":"The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation","volume":"33","author":"Salat","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.ATV.18.11.1796","article-title":"NO inhibits cytokine-induced iNOS expression and NF-\u03baB activation by interfering with phosphorylation and degradation of I\u03baB-\u03b1","volume":"18","author":"Katsuyama","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardiores.2004.03.014","article-title":"NO suppresses while peroxynitrite sustains NF-\u03baB: A paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO","volume":"63","author":"Hattori","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1025036530605","article-title":"Nitric oxide modulates MCP-1 expression in endothelial cells: Implications for the pathogenesis of pulmonary granulomatous vasculitis","volume":"27","author":"Desai","year":"2003","journal-title":"Inflammation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/306174a0","article-title":"Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation","volume":"306","author":"Rapoport","year":"1983","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.91.16.7583","article-title":"Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase","volume":"91","author":"Archer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.95.9.4888","article-title":"Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2006-10-053827","article-title":"A new mechanism for nitric oxide- and cGMP-mediated platelet inhibition","volume":"109","author":"Du","year":"2007","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"41383","DOI":"10.1074\/jbc.M107566200","article-title":"TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells","volume":"276","author":"Hoffmann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.niox.2010.02.004","article-title":"Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: A basis for shear stress mediated angiogenesis","volume":"22","author":"Kolluru","year":"2010","journal-title":"Nitric Oxide Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bpj.2016.05.034","article-title":"Shear-Induced Nitric Oxide Production by Endothelial Cells","volume":"111","author":"Sriram","year":"2016","journal-title":"Biophys. J."},{"key":"ref_91","first-page":"211","article-title":"Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-alpha and IL-1-beta","volume":"81","author":"Cunha","year":"1994","journal-title":"Immunology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41467-021-21066-x","article-title":"High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-62703-128-8_14","article-title":"Generation and characterization of murine alternatively activated macrophages","volume":"946","author":"Weisser","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-6576.1999.430307.x","article-title":"The role of nitric oxide in sepsis--an overview","volume":"43","author":"Strand","year":"1999","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0304-4165(96)00139-0","article-title":"Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis","volume":"1335","author":"Zhou","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1081\/JDI-100001282","article-title":"Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells","volume":"23","author":"Lima","year":"2001","journal-title":"Ren. Fail."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/01.CIR.90.6.3018","article-title":"Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries","volume":"90","author":"Sudhir","year":"1994","journal-title":"Circulation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V84.7.2363.2363","article-title":"Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation","volume":"84","author":"Drobyski","year":"1994","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.1840380416","article-title":"Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome","volume":"38","author":"DeLeve","year":"2003","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.bioeng.9.060906.151959","article-title":"The Structure and Function of the Endothelial Glycocalyx Layer","volume":"9","author":"Weinbaum","year":"2007","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10439-011-0429-8","article-title":"Endothelial glycocalyx: Permeability barrier and mechanosensor","volume":"40","author":"Curry","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","article-title":"Exploring traditional and nontraditional roles for thrombomodulin","volume":"132","author":"Loghmani","year":"2018","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Kato, Y., Nishida, O., Kuriyama, N., Nakamura, T., Kawaji, T., Onouchi, T., Hasegawa, D., and Shimomura, Y. (2021). Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094933"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1476-5381.2009.00251.x","article-title":"Protective mechanisms of activated protein C in severe inflammatory disorders","volume":"158","author":"Neyrinck","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00540-021-02971-3","article-title":"Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: A preliminary study","volume":"35","author":"Hirata","year":"2021","journal-title":"J. Anesth."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.13991","article-title":"Thrombomodulin Attenuates Inflammatory Damage Due to Liver Ischemia and Reperfusion Injury in Mice in Toll-Like Receptor 4-Dependent Manner","volume":"17","author":"Kadono","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1182\/blood.V99.10.3646","article-title":"Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function","volume":"99","author":"Kunz","year":"2002","journal-title":"Blood"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101247","DOI":"10.1016\/j.trim.2019.101247","article-title":"Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Nomura","year":"2019","journal-title":"Transpl. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1076029614523490","article-title":"Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin \u03b1) in Pediatric Patients With Disseminated Intravascular Coagulation","volume":"20","author":"Shirahata","year":"2014","journal-title":"Clin. Appl. Thromb.\/Hemost."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00431-013-2155-8","article-title":"Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation","volume":"173","author":"Shirahata","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: New therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Licht","year":"2008","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1182\/blood.V114.22.5127.5127","article-title":"Regulation of Complement Activation by Thrombomodulin","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cei.13497","article-title":"MASP2 levels are elevated in thrombotic microangiopathies: Association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab","volume":"203","author":"Elhadad","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Saffarzadeh, M., Juenemann, C., Queisser, M.A., Lochnit, G., Barreto, G., Galuska, S.P., Lohmeyer, J., and Preissner, K.T. (2012). Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032366"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.devcel.2018.01.019","article-title":"Neutrophil Extracellular Traps: The Biology of Chromatin Externalization","volume":"44","author":"Sollberger","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1042\/CS103S031S","article-title":"Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors","volume":"103","author":"Boros","year":"2002","journal-title":"Clin. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/S0962935194000207","article-title":"Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1","volume":"3","author":"Helset","year":"1994","journal-title":"Mediators Inflamm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-3940(93)90432-K","article-title":"Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells","volume":"156","author":"McCarron","year":"1993","journal-title":"Neurosci. Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/00003246-200006000-00028","article-title":"Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines","volume":"28","author":"Tschaikowsky","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2013-10-530469","article-title":"Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro","volume":"123","author":"Danesh","year":"2014","journal-title":"Blood"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12185-021-03113-x","article-title":"Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD","volume":"113","author":"Nagasawa","year":"2021","journal-title":"Int. J. Hematol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.16621","article-title":"Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation","volume":"190","author":"Hildebrandt","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","article-title":"Allogeneic reactivity\u2013mediated endothelial cell complications after HSCT: A plea for consensual definitions","volume":"3","author":"Pagliuca","year":"2019","journal-title":"Blood Adv."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/toxsci\/kfz193","article-title":"Liver Inflammatory Injury Initiated by DAMPs-TLR4-MyD88\/TRIF-NF\u03baB Signaling Pathway Is Involved in Monocrotaline-Induced HSOS","volume":"172","author":"Huang","year":"2019","journal-title":"Toxicol. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.bbmt.2017.08.021","article-title":"Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes","volume":"23","author":"Saliba","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bmt.1704224","article-title":"Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: A retrospective review of 216 patients","volume":"32","author":"Choi","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbmt.2020.01.028","article-title":"Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation","volume":"26","author":"Varma","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood.V99.8.2940","article-title":"CD95 engagement induces disseminated endothelial cell apoptosis in vivo: Immunopathologic implications","volume":"99","author":"Janin","year":"2002","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.TP.0000128839.13674.02","article-title":"A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome","volume":"78","author":"Gerbitz","year":"2004","journal-title":"Transplantation"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood-2003-12-4259","article-title":"Donor-derived TNF-\u03b1 regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"104","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41409-017-0042-z","article-title":"Endothelial cell damage in idiopathic pneumonia syndrome","volume":"53","author":"Altmann","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood-2014-12-617035","article-title":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: Evidence of occult infectious etiologies","volume":"125","author":"Seo","year":"2015","journal-title":"Blood"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Parikh, S.M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S.A., and Sukhatme, V.P. (2006). Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030046"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e0295","DOI":"10.1097\/CCE.0000000000000295","article-title":"Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome","volume":"2","author":"Whitney","year":"2020","journal-title":"Crit. Care Explor."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: Double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1703855","article-title":"Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria","volume":"31","author":"Maiolino","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1703324","article-title":"Engraftment syndrome: A common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"29","author":"Oyama","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0609.2008.01037.x","article-title":"Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome","volume":"80","author":"Dispenzieri","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2010.09.013","article-title":"Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome","volume":"17","author":"Koreth","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ajh.23716","article-title":"Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults","volume":"89","author":"Omer","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2014.05.022","article-title":"Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes","volume":"20","author":"Chang","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u201cnovel\u201d target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41409-018-0293-3","article-title":"High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease","volume":"54","author":"Kraft","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: A clinical imitator of acute enteric graft-versus-host disease","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation","volume":"21","author":"Warren","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: A study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1097\/HS9.0000000000000487","article-title":"Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation","volume":"5","author":"Gavriilaki","year":"2021","journal-title":"HemaSphere"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Transfus. Apher. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/bmt.2008.350","article-title":"Nitric oxide in transplantation-related thrombotic microangiopathy","volume":"43","author":"Thachil","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00005344-200501000-00014","article-title":"The impact of immunosuppression on endothelial function","volume":"45","author":"Trapp","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0008-6363(03)00354-7","article-title":"Infections and endothelial cells","volume":"60","author":"Keller","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_172","first-page":"646","article-title":"Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation","volume":"7","author":"Sinkovits","year":"2020","journal-title":"Front. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3389\/fimmu.2021.695037","article-title":"Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy","volume":"12","author":"Okamura","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation","volume":"24","author":"Csuka","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2017.121","article-title":"Endothelial damage is aggravated in acute GvHD and could predict its development","volume":"52","author":"Mir","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41409-019-0474-8","article-title":"Systematic review of defibrotide studies in the treatment of veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS)","volume":"54","author":"Richardson","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","article-title":"Defibrotide: Properties and clinical use of an old\/new drug","volume":"59","author":"Pescador","year":"2013","journal-title":"Vascul. Pharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12288-017-0904-y","article-title":"Successful Treatment of Transplant Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide","volume":"34","author":"Devadas","year":"2018","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1111\/jcmm.15434","article-title":"Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease","volume":"24","author":"Palomo","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JBM.S102235","article-title":"Hematopoietic cell transplantation-associated thrombotic microangiopathy: A review of pathophysiology, diagnosis, and treatment","volume":"7","author":"Rosenthal","year":"2016","journal-title":"J. Blood Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC","volume":"99","author":"Galambrun","year":"2015","journal-title":"Transplantation"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/trf.15534","article-title":"Approaching treatment of transplant-associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus","volume":"59","author":"Jan","year":"2019","journal-title":"Transfusion"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3389\/fimmu.2020.564647","article-title":"Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"152001","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Poppelaars, F., Faria, B., Schwaeble, W., and Daha, M.R. (2021). The contribution of complement to the pathogenesis of IgA nephropathy: Are complement-targeted therapies moving from rare disorders to more common diseases?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204715"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ekir.2020.08.003","article-title":"Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy","volume":"5","author":"Lafayette","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.12998\/wjcc.v8.i12.2617","article-title":"Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report","volume":"8","author":"Chen","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref_193","first-page":"1194","article-title":"Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease","volume":"33","author":"Niewold","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_194","first-page":"72","article-title":"Successful treatment of transplant-associated microangiopathy with rituximab","volume":"122","author":"Marr","year":"2009","journal-title":"N. Z. Med. J."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705657","article-title":"Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient","volume":"39","author":"Ostronoff","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-0609.2006.00758.x","article-title":"Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab","volume":"77","author":"Gallerani","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0022-4804(89)90026-7","article-title":"Cyclosporine inhibits endothelial cell prostacyclin production","volume":"46","author":"Rosenthal","year":"1989","journal-title":"J. Surg. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00007890-198804000-00025","article-title":"Cyclosporine suppression of endothelial prostacyclin generation. A possible mechanism for nephrotoxicity","volume":"45","author":"Voss","year":"1988","journal-title":"Transplantation"},{"key":"ref_199","first-page":"476","article-title":"Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity","volume":"84","author":"Conde","year":"1995","journal-title":"Immunology"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","article-title":"Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2","volume":"193","author":"Volpert","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","article-title":"Transplantation-associated thrombotic microangiopathy: Twenty-two years later","volume":"30","author":"Daly","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2018.08.016","article-title":"Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience","volume":"25","author":"Sartain","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1537-2995.2000.40080896.x","article-title":"Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome","volume":"40","author":"Rizvi","year":"2000","journal-title":"Transfusion"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1537-2995.2008.02030.x","article-title":"Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008","volume":"49","author":"Nguyen","year":"2009","journal-title":"Transfusion"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1537-2995.2006.00687.x","article-title":"Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"46","author":"Howard","year":"2006","journal-title":"Transfusion"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"e13269","DOI":"10.1111\/petr.13269","article-title":"Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants","volume":"22","author":"Yamamoto","year":"2018","journal-title":"Pediatr. Transplant."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2009.242","article-title":"Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin","volume":"45","author":"Sakai","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/lt.24411","article-title":"Possible efficacy of recombinant human soluble thrombomodulin for the treatment of thrombotic microangiopathy after liver transplantation","volume":"22","author":"Ito","year":"2016","journal-title":"Liver Transplant."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/trf.13437","article-title":"Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"56","author":"Fujiwara","year":"2016","journal-title":"Transfusion"},{"key":"ref_213","first-page":"1560","article-title":"Successful treatment with recombinant thrombomodulin in transplant-associated thrombotic microangiopathy following HLA-haploidentical transplantation","volume":"60","author":"Otsuka","year":"2019","journal-title":"Rinsho. Ketsueki."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/bmt.2010.158","article-title":"Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome","volume":"46","author":"Ikezoe","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/bmt.2009.217","article-title":"Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"45","author":"Ikezoe","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/bmt.2016.179","article-title":"Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation","volume":"51","author":"Inagaki","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1741826711398430","article-title":"Effects of statins on coronary and peripheral endothelial function in humans: A systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Reriani","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","article-title":"Statins and the endothelium","volume":"46","author":"Ii","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.leukres.2017.01.017","article-title":"Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model","volume":"55","author":"Zheng","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3324\/haematol.2019.238790","article-title":"Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel","volume":"106","author":"Jiang","year":"2021","journal-title":"Haematologica"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-017-1851-6","article-title":"Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia","volume":"21","author":"Gutbier","year":"2017","journal-title":"Crit. Care"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Latreille, E., and Lee, W.L. (2021). Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses, 13.","DOI":"10.3390\/v13020161"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1177\/0963689718791568","article-title":"Angiopoietin-1 Mimetic Peptide Promotes Neuroprotection after Stroke in Type 1 Diabetic Rats","volume":"27","author":"Venkat","year":"2018","journal-title":"Cell Transplant."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cns.13541","article-title":"Treatment with an Angiopoietin-1 mimetic peptide promotes neurological recovery after stroke in diabetic rats","volume":"27","author":"Venkat","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ALN.0000000000001907","article-title":"Vasculotide, an Angiopoietin-1 Mimetic, Restores Microcirculatory Perfusion and Microvascular Leakage and Decreases Fluid Resuscitation Requirements in Hemorrhagic Shock","volume":"128","author":"Trieu","year":"2018","journal-title":"Anesthesiology"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Sanwal, R., Joshi, K., Ditmans, M., Tsai, S.S.H., and Lee, W.L. (2021). Ultrasound and Microbubbles for Targeted Drug Delivery to the Lung Endothelium in ARDS: Cellular Mechanisms and Therapeutic Opportunities. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070803"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.biocel.2007.07.016","article-title":"TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin","volume":"40","author":"Subramaniyam","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2017.00146","article-title":"Heme as a Target for Therapeutic Interventions","volume":"8","author":"Immenschuh","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.bbmt.2020.05.014","article-title":"Human-Derived \u03b11-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease","volume":"26","author":"Giannoni","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1189\/jlb.0313147","article-title":"Modification of heparanase gene expression in response to conditioning and LPS treatment: Strong correlation to rs4693608 SNP","volume":"95","author":"Ostrovsky","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1073\/pnas.1011811108","article-title":"Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions","volume":"108","author":"Taflin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2021.01.006","article-title":"Endothelium-derived stromal cells contribute to hematopoietic bone marrow niche formation","volume":"28","author":"Kenswil","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1152\/physiol.00025.2005","article-title":"The bone marrow vascular niche: Home of HSC differentiation and mobilization","volume":"20","author":"Kopp","year":"2005","journal-title":"Physiology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/623\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:11Z","timestamp":1760134091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":234,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["jcm11030623"],"URL":"https:\/\/doi.org\/10.3390\/jcm11030623","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}